← Back to patent-cliff list
尤瑞克林
Tier C — Watch / tradeUrinary Kallidinogenase
广东天普生化医药股份有限公司
Originator
2005
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Kininogens
Brand：凯力康
Indications (approved)：脑梗死
Regional status
US
-
EU
-
China
批准上市
2005-10-19
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Urinary Kallidinogenase?
Approved indications include: 脑梗死.
When does the Urinary Kallidinogenase patent expire?
No public expiry year is available for Urinary Kallidinogenase yet; this page updates once verified.
How do I get a quote for Urinary Kallidinogenase intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24